Evidence map›Paper›PMID 25463477›Full record

ReviewBiochimica et biophysica acta2015

Phosphoinositides: Key modulators of energy metabolism.

Dave Bridges, Alan R Saltiel

Open access · greenAbstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. PI3K and AKT at the Interface of Signaling and Metabolism.Current topics in microbiology and immunology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Dave BridgesDepartments of Physiology and Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA; Children's Foundation Research Institute, Le Bonheur Children's Hospital, Memphis, TN, USA. Electronic address: dbridge9@uthsc.edu.
Alan R SaltielLife Sciences Institute, University of Michigan, Ann Arbor, MI, USA.
University of Michigan–Ann Arbor · USUniversity of Tennessee Health Science Center · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
The Role of G Proteins in Insulin ActionR01DK061618 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SALTIEL, ALAN R. · 2002 to 2016
$5.1M
Signaling Pathways in Insulin ActionR01DK060591 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SALTIEL, ALAN R. · 2002 to 2016
$4.9M
NIDDK NIH HHS DK060591NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK060591NIDDK NIH HHS R01 DK061618NIDDK NIH HHS R01DK061618
6 · The paper itself

Abstract

Phosphoinositides are key players in many trafficking and signaling pathways. Recent advances regarding the synthesis, location and functions of these lipids have dramatically improved our understanding of how and when these lipids are generated and what their roles are in animal physiology. In particular, phosphoinositides play a central role in insulin signaling, and manipulation of PtdIns(3,4,5)P₃levels in particular, may be an important potential therapeutic target for the alleviation of insulin resistance associated with obesity and the metabolic syndrome. In this article we review the metabolism, regulation and functional roles of phosphoinositides in insulin signaling and the regulation of energy metabolism. This article is part of a Special Issue entitled Phosphoinositides.

Indexed as

AnimalsEnergy MetabolismGene Expression RegulationGlucose Transporter Type 4HumansInsulinLiverMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesMuscle, SkeletalPhosphatidylinositol PhosphatesProtein TransportProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine KinasesGlucose Transporter Type 4InsulinMechanistic Target of Rapamycin Complex 1Multiprotein Complexesphosphatidylinositol 3,4,5-triphosphatephosphatidylinositol 3,5-diphosphatePhosphatidylinositol PhosphatesProto-Oncogene Proteins c-aktSLC2A4 protein, humanTOR Serine-Threonine KinasesAktGLUT4mTORC1PhosphatidylinositolPhosphorylated phosphatidylinositidesPtdIns(3,4,5)P(3)

Identifiers

PMID25463477
PMCPMC4975561
OpenAlexW2000190196

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.